Thrombolex, Inc. Employee Directory
Medical Equipment ManufacturingPennsylvania, United States11-50 Employees
Thrombolex, Inc. designs, develops, and distributes endovascular catheters used in interventional procedures for arterial and venous thromboembolic diseases. The portfolio supports pharmaco-mechanical catheter-directed thrombolysis (PM-CDT) and currently includes seven FDA-cleared devices based on the BASHIR Endovascular Catheter platform. It is based in Doylestown, Pennsylvania, and operates as a small to mid-sized medical device company. Its customers are healthcare providers performing interventional procedures to treat thromboembolic diseases, with a focus on pulmonary embolism and related conditions. In June 2026, the company announced the appointment of Michael Tutera as Chief Executive Officer.